Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 7 Stomach Neoplasms 4 Barrett Esophagus 3 Polyps 2 Neoplasms 2 Lung Neoplasms 2 Laryngeal Diseases 2 Hypopharyngeal Neoplasms 2 Head and Neck Neoplasms 2 Esophageal Neoplasms 2 Colonic Polyps 2 Colonic Neoplasms 2 Carcinoma, Squamous Cell 2 Adenomatous Polyps 2 Adenoma 2 Urinary Bladder Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Papilloma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Oropharyngeal Neoplasms 1 Nasopharyngeal Carcinoma 1 Margins of Excision 1 Laryngeal Neoplasms 1 Inflammatory Bowel Diseases 1 Hypersensitivity 1 Gastrointestinal Neoplasms 1 Fallopian Tube Neoplasms 1 Esophageal Squamous Cell Carcinoma 1 Endometrial Neoplasms 1

Interventions

Cisplatin 127 Gemcitabine 71 Radiotherapy, Intensity-Modulated 61 toripalimab 39 Capecitabine 37 Docetaxel 36 Fluorouracil 35 Radiotherapy 24 camrelizumab 23 Drug Therapy 22 nimotuzumab 18 spartalizumab 13 pembrolizumab 13 nedaplatin 12 Chemoradiotherapy 12 sintilimab 11 apatinib 11 Induction Chemotherapy 11 Immune Checkpoint Inhibitors 11 tislelizumab 10 Nivolumab 10 Magnetic Resonance Spectroscopy 10 Specimen Handling 9 Radiation 9 Cetuximab 9 Carboplatin 9 endostar protein 8 Paclitaxel 8 Bevacizumab 8 anlotinib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Carcinoma × Narrow Band Imaging × Clear all

NCT04593186 2023-09-07

Magnifying NBI for Occult NPC

Chinese University of Hong Kong

Phase NA Unknown

Nasopharyngeal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡